Course Overview

According to the National Eczema Association, approximately 3 million children and over 6 million adults in the US have moderate-to-severe atopic dermatitis (AD). Many of these patients experience burdensome symptoms, including itch, erythema, and sleep loss, and many report inadequate disease control. 

Advanced practice providers in the field of dermatology are often on the front lines regarding patient interactions, disease management, and treatment selection and administration. As such, the need for tailored education that addresses the clinical gaps currently observed in the management of moderate to severe AD must be acknowledged and remedied. 

This live webinar, featuring expert leaders in the study and treatment of this disease, will serve to help advanced practice providers improve their confidence and skills in the diagnosis and treatment of their patients with atopic dermatitis.

Webinar Agenda

Wednesday December 7, 2022
7:00 PM - 7:05 PM
Wednesday December 7, 2022
7:05 PM - 7:15 PM
Clinical Features of Atopic Dermatitis
7:15 PM - 7:25 PM
Current Treatment Algorithm
7:25 PM - 7:35 PM
Pathophysiology and Key Pathways
7:35 PM - 7:50 PM
New and Emerging Agents
7:50 PM - 8:20 PM
Regeneron Sanofi Non CME: A Treatment Option for Patients with Uncontrolled Moderate-to-Severe Atopic Dermatitis, 
Sandri Johnson, MSN, FNP-BC
8:20 PM - 8:35 PM
Patient Communication and Education Strategies
8:35 PM - 8:45 PM
Expert Case Discussion
8:45 PM - 8:55 PM
Conclusion / Q&A Session


Matthew J. Zirwas, MD
Medical Dermatologist
James R. Treat, MD
Pediatric Dermatologist
Alexandra K. Golant, MD
Alexandra K. Golant, MD


Webinar Registration